Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Table 2 Bivariate unadjusted associations with MOUD retention

Variable	Odds Ratio	95% CI		P-value (from Wald’s χ²test)
Age	1.00	0.97	1.03	0.95
Gender	0.48	0.21	1.11	0.09
MINI Major Depressive Disorder, Current or Past	1.04	0.48	2.24	0.92
High dose of MOUD^a	4.12	1.91	8.89	0.00
Frequency of cocaine use	0.95	0.40	2.25	0.91
Houseless	0.46	0.21	1.01	0.05
Opioid Craving Score	0.96	0.86	1.07	0.44
WHOQoL BREF physical	0.95	0.85	1.05	0.29
WHOQoL BREF psychological	1.02	0.92	1.14	0.67
WHOQoL BREF—social relationships	1.09	0.99	1.20	0.09
WHOQoL BREF—environment	1.11	0.98	1.27	0.11
HIV status	0.92	0.43	1.94	0.82
Satisfaction with transportation	1.13	0.85	1.50	0.41
Pain interference	1.44	1.07	1.94	0.02
Referred to treatment by prison/jail	1.00	0.38	2.68	0.99
Employed	0.88	0.36	2.16	0.78

MOUD medications for opioid use disorder; MINI Mini International Neuropsychiatric Interview; WHOQoL BREF World Health Organization Quality of Life, 26 item version
^aHigh dose of MOUD defined as methadone dose > 85 mg or buprenorphine dose ≥ 16 mg

ISSN: 1940-0640